Zinc at concentrations of 150 µM or higher induced necrosis as well as apoptosis in thyroid cancer cell lines. Necrosis was induced by zinc in a dose-dependent manner, whereas apoptosis did not increase at higher concentrations of zinc. The expression of the antiapoptotic protein phosphorylated Bad was markedly increased, whereas the expression of the proapoptotic proteins Bax and Bad decreased following Zn 2+ exposure. Zn 2+ induced rapid degradation of I B, and an increase in the binding of nuclear transcription factor-B (NF-B). These observations indicate that antiapoptotic pathways were activated in thyroid cancer cells following exposure to Zn 2+ . This may be a self-defence mechanism against apoptosis and may underlie the general resistance of thyroid cancer cells to apoptotic stimuli. Zinc may be a potential cytotoxic agent for the treatment of thyroid cancer.
Introduction
Zinc is an essential component of a wide variety of metalloenzymes, transcription factors and other proteins. A deficiency in zinc affects various organs including the nervous system, gonadal tissue, skin and the intestine. Ingestion or administration of excessive amounts of zinc compounds, on the other hand, does not seem to result in any adverse long-term effects (Vallee & Falchuk 1993) .
Most physiologically relevant cell death in the body occurs by an active process of self-destruction known as programmed cell death or apoptosis. Apoptosis can be initiated by a number of external signals including glucocorticoids, irradiation, cytokines, or withdrawal of growth factors (Raff 1992 , Williams & Smith 1993 . Several studies have indicated that zinc can inhibit apoptotic cell death. Apoptosis was observed in the small intestine of animals on a zinc-deficient diet (Elmes 1977) , and a zinc-chelator was found to induce apoptosis in human thymocytes and leukemia cells (McCabe et al. 1993) . The induction of apoptosis by irradiation, anti-cancer drugs or tumor necrosis factor (TNF) was prevented by zinc (Shimizu et al. 1990 , Telford et al. 1991 , Zalewski et al. 1991 , Leccia et al. 1993 , Fady et al.1995 . In contrast, however, a few reports have suggested that zinc actually induces apoptotic cell death (Telford & Fraker 1995 , Manev et al. 1997 , Paramanantham et al. 1997 . Furthermore, zinc induced necrosis in prostate carcinoma cells (Iguchi et al. 1998) .
In the present study, we show that zinc induced both necrosis and apoptosis in thyroid cancer cells. After exposure to zinc, the expression of antiapoptotic proteins was increased, and that of proapoptotic proteins was decreased. Furthermore, nuclear factor-B (NF-B) was activated. These changes may be a protective mechanism of thyroid cancer cells against apoptotic cell death, and may underlie the general resistance of thyroid cancer cells to apoptotic stimuli (Arscott et al. 1997) .
Materials and Methods

Materials
Antibodies to Bcl-2, Bax, Bcl-xL, NFKB1, RelA, c-Rel, I B and actin were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Antibodies to Bad and phosphorylated Bad (serine 112/136) were from New England BioLabs Inc. (Beverly, MA, USA). A caspase inhibitor, Ac-DEVD-CHO (Ac-Asp-Glu-ValAsp-CHO), was purchased from Peptide Institute Inc. (Osaka, Japan). RNase A and proteinase K were from Nippon Gene (Osaka, Japan). T4 polynucleotide kinase and poly(dI-dC)·poly(dI-dC) were from Promega (Madison, WI, USA). Hoechst 33342 and propidium iodide (PI) were purchased from Wako Chemical Co.
(Osaka, Japan). A TACS annexin V(ANV)-FITC apoptosis detection kit was from Trevigen Inc. (Gaithersburg, MD, USA).
Cell culture and treatment
The rat thyroid cancer cell line, FRTC, derived from FRTL-5, has been described previously (Iitaka et al. 1997) . Cell lines 8505C (poorly differentiated human papillary thyroid carcinoma), 8305C (undifferentiated human thyroid anaplastic carcinoma) and 3T3-L1 (mouse pre-adipocytes) were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). FRO (human anaplastic thyroid carcinoma) (Namba et al. 1995) and MO7-E (human megakaryoblastic leukemia cells) (Avanzi et al. 1990) were obtained from Drs Namba (Nagasaki University, Japan) and Murohashi (Saitama Medical School, Japan) respectively. Human hepatocellular carcinoma cell line HepG2 (American Type Culture Collection, ATCC HB 8065) was purchased from Dainippon Pharmatheuticals (Osaka, Japan). Thyroid cells were cultured in Ham F12 medium supplemented with 10% fetal calf serum (FCS). MC3T3-E1 (mouse osteoblastic cell line, Iitaka et al. 1994) , 3T3-L1, and HepG2 cells were cultured in -MEM supplemented with 10% FCS. MO7-E cells were cultured in RPMI 1640 supplemented with 10% FCS and GM-CSF. Cells were incubated in 24-well microtiter plates (Nunc, Roskilde, Denmark) at a concentration of 1 10 4 cells per well, and exposed to 10-500 µM ZnCl 2 , FeSO 4 , MnCl 2 , or CuSO 4 for 24 h at 37 C. In some experiments, cells were pretreated with 100 µM Ac-DEVD-CHO for 1 h before adding ZnCl 2 . Live epithelial cells were counted by the crystal violet method (Iitaka et al. 1994) , and MO7-E cells were quantified by the trypan blue exclusion method.
Detection of apoptosis and necrosis
Cells were stained with FITC-ANV (TACS annexin V-FITC apoptosis detection kit) to measure externalization of phosphatidyl serine, an early marker of apoptosis. Cells were also stained with Hoechst 33342 or PI after exposure to Zn 2+ . Hoechst 33342 stains the nuclei in both apoptotic and necrotic cells, while PI stains the nuclei in cells with damaged cell membrane (necrosis). Cells were examined under a Zeiss axioplan fluorescence microscope (Oberkochen, Germany) or analyzed by a FACScan flow cytometer (Beckton Dickinson, San Jose, CA, USA) as previously reported (van Engeland et al. 1996) . DNA ladder formation was observed as described previously (Gong et al. 1994) . Briefly, 1 10 6 Zn 2+ -treated or untreated cells were collected and washed twice with cold phosphate-buffered saline (PBS). Pellets were fixed with 70% ethanol for 20 h at 4 C. After being washed twice with cold PBS, the cells were treated with 0·2 M phosphate-citrate buffer, pH 7·8, for 30 min at room temperature. The supernatants were recovered by centrifugation and incubated with 1 mg/ml RNase A (Nippon Gene) for 1 h at 37 C, followed by proteinase K (1 mg/ml; Nippon Gene) for 1 h at 37 C. DNA fragments were precipitated with 2·5 vol ethanol in the presence of 0·5 vol 10 M ammonium acetate at 20 C for 20 h. After centrifugation, samples were washed with 70% ethanol and resuspended in loading buffer. Electrophoresis was performed in 1 TBE (50 mM Tris-HCl, pH 8·3, 50 mM boric acid, 1 mM EDTA) buffer on 1·5% agarose gels containing ethidium bromide.
Electrophoretic mobility shift assay (EMSA)
To examine the activation of NF-B, an EMSA was performed as described previously (Watanabe et al. 1997) . Whole cell and nuclear extracts were prepared after lysis of the cells with NP-40 lysis buffer. An oligonucleotide containing the NF-B consensus binding site (5 -AGT TGAGGGGACTTTCCCAGGC-3 ) was 5 end-labeled using polynucleotide kinase and [ -32 P]ATP. Nuclear protein extracts (4 µg) or whole cell extracts (10 µg) were incubated with labeled oligonucleotide for 20 min at room temperature in 10 µl binding mixture containing 10 mM Tris-HCl, pH 7·5, 1 mM MgCl 2 , 50 mM NaCl, 0·5 mM EDTA, 0·5 mM dithiothreitol, 4% glycerol, and 0·05 mg/ml poly(dI-dC)·poly(dI-dC). The DNA-protein complexes were resolved by electrophoresis on 4% acrylamide gels in 1 TBE at 10 V/cm for 60 min at room temperature.
Western blotting
The expression of Bcl-2, Bcl-xL, Bax, Bad, phosphorylated Bad (ser 112/136) and I B was examined by Western blot analysis. Cell lysates were separated by SDS-PAGE on 7·5 12% gradient polyacrylamide gels and transferred onto Hybond-ECL nitrocellulose membranes (Amersham International plc, Amersham, Bucks, UK) in 25 mM Tris, 192 mM glycine. Membranes were blocked in Tris-buffered saline (20 mM Tris-HCl, pH 7·5, 137 mM NaCl) containing 0·1% Tween 20 and 3% non-fat dry milk for 30 min at room temperature. The blots were incubated with antibodies to Bcl-2, Bcl-xL, Bax, Bad, phospho-Bad, and I B overnight at 4 C. The membranes were washed in Tris-buffered saline and incubated with horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (Amersham) for 1 h at room temperature. The blots were visualized by the Amersham ECL system (Amersham). The expression of these proteins was quantified using NIH image software (NIH, Bethesda, MD, USA). 
Statistical analysis
The Scheffé's multiple comparison test (Figs 1 and 2 ) and the Student's t-test (Fig. 6B ) were used to analyze data. A level of P<0·05 was accepted as statistically significant.
Results
Zn
2+ -induced cell death in thyroid cancer cells
As shown in Fig. 1 , Fe 2+ and Mn 2+ had no significant cytotoxic effect on these cells, even at concentrations as high as 500 µM (Fig. 2A) . Non-thyroid cell lines, including MC3T3-E1, 3T3-L1 and MO7-E, were resistant to exposure to Zn 2+ concentrations up to 300 µM (Fig. 2B) . However, 300 µM Zn 2+ had a significant cytotoxic effect on HepG2 cells. ZnCl 2 at 500 µM also had a significant cytotoxic effect on MO7-E cells (number of viable cells was 54 10% of the control), but not on MC3T3-E1 and 3T3-L1 cells.
Cells with apoptotic bodies and DNA laddering were observed in Zn 2+ -treated thyroid cancer cells (Fig. 3) . Flow cytometric analysis showed that the number of PI(+) necrotic cells as well as ANV(+)/PI( ) apoptotic cells increased after exposure to 150 µM or higher concentrations of zinc (Fig. 4) . Necrosis was induced by zinc in a dose-dependent manner (Fig. 5) . However, apoptotic cells were not further increased by 200 µM or higher concentrations of zinc. As the concentration of zinc increased, the number of ANV(+)/PI(+) cells (including secondary necrotic cells following apoptosis) also increased. As shown in Fig. 6A , cells were rapidly killed through necrosis following 300 µM zinc administration. On the other hand, apoptosis as well as necrosis were gradually induced by 180 µM zinc. The cytotoxic effect of 180 µM zinc was significantly inhibited by the caspase inhibitor Ac-DEVD-CHO, whereas cell death induced by 300 µM zinc was not inhibited (Fig. 6B) .
Zn
2+ -induced DNA binding activity of NF-B
The inhibitory protein I B was degraded rapidly and increased binding of NF-B in thyroid cancer cells was observed following Zn 2+ exposure (Fig. 7) . Supershift analysis revealed that activated NF-B was mainly a heterodimer of NFKB1 and RelA (Fig. 7) .
Expression of proapoptotic and antiapoptotic proteins after Zn 2+ exposure
The expression of the proapoptotic proteins Bax and Bad was significantly decreased after exposure to 200 µM Zn 2+ (Fig. 8) . The expression of phosphorylated Bad at serine 112 and 136, which exerts antiapoptotic effects, was gradually but markedly increased. A slight increase in expression of the antiapoptotic protein Bcl-2 was observed. There was no significant change in the expression of Bcl-xL. These changes were not observed in zinc-resistant MC3T3E-1 cells even after 500 µM zinc treatment (data not shown).
Discussion
This study demonstrated that Zn 2+ had a potent cytotoxic effect on thyroid cancer cell lines and FRTL-5. High concentrations of ZnCl 2 induced both necrosis and apoptosis. Previous reports have shown that Zn 2+ prevented apoptotic cell death in various cell types when apoptosis was induced with various cytotoxic agents including TNF , cycloheximide, and UV and -irradiation (Shimizu et al. 1990 , Telford et al. 1991 , Zalewski et al. 1991 , Leccia et al. 1993 , Fady et al. 1995 . The mechanism of the antiapoptotic effect of Zn 2+ was thought to be via its inhibitory effect on DNases , or on poly(ADP-ribose) synthetase (Shimizu et al. 1990 ). Conversely, Zn 2+ appeared to induce apoptotic cell death in a particular subset of mouse thymocytes, rat cerebellar granule cells and human liver cells (Telford & Fraker 1995 , Manev et al. 1997 , Paramanantham et al. 1997 . We also confirmed the cytotoxic effect of Zn 2+ on HepG2 cells. Telford et al. (1991) and Telford and Fraker (1995) reported that high concentrations (>200 µM) of Zn 2+ inhibited glucocorticoid-induced apoptosis in mouse thymocytes, whereas lower concentrations (80-200 µM) of Zn 2+ were shown to induce apoptotic cell death in these cells. Provinciali et al. (1995) also reported a similar dose-dependent effect of Zn 2+ on apoptosis in mouse thymocytes. In the present study, concentrations of Zn 2+ at 150 µM or higher were observed to induce cell death in various thyroid cancer cell lines in a dose-dependent manner. Manev et al. (1995 Manev et al. ( , 1997 have shown that the neurotoxicity of Zn 2+ on rat cerebellar granule neurons involved both necrotic and apoptotic cell death. They suggested that calcium channel blocker-sensitive mitochondrial injury and DNA damage were involved in the protein synthesisdependent neurotoxicity of Zn
2+
. These authors reported that actinomycin D and calcium channel blockers reduced mitochondrial injury and cell death. In our study, we did not observe any inhibitory effect of actinomycin D or calcium channel blockers on Zn
-induced cell death in thyroid cancer cells (data not shown). Zinc has also been reported to induce necrosis in prostate carcinoma cells (Iguchi et al. 1998 ).
The present study shows that necrosis was induced in a dose-dependent manner by zinc. Higher concentrations of zinc rapidly induced necrotic cell death, whereas relatively lower concentrations of zinc induced apoptosis as well as necrosis in a time-dependent fashion. This suggests that zinc can induce two cytotoxic pathways in thyroid cancer cells. It is of interest that about 65% of cell death induced by 180 µM zinc could be rescued by the caspase inhibitor in spite of the fact that only 20% of cells are supposed to be killed by apoptosis. This suggests that secondary necrosis may be induced following apoptosis by relatively lower concentrations of zinc. Blom et al. (1999) reported that permeabilization of the plasma membrane (i.e. necrosis) was induced in some hepatocytes after the induction of apoptosis. Another possibility is that the caspase inhibitor actually inhibited necrosis. Warny and Kelly (1999) showed that caspase-like proteases were activated when necrosis was induced, and that the caspase inhibitor inhibited necrosis. In our experiments, however, the caspase inhibitor could not inhibit the cytotoxic effect of 300 µM zinc. We do not know why higher concentrations of zinc still induce apoptosis in a minor population of thyroid cancer cells. Palomba et al. (1996) found that the same initial damage can be a triggering event for both apoptosis and necrosis. They concluded that necrosis does not appear to be a passive response to overwhelming damage. Although the mechanism of induction of apoptosis or necrosis by zinc still remains to be elucidated, it was reported that intracellular ATP (Eguchi et al. 1997 , Leist et al. 1997 or reduced glutathione (Fernandes & Cotter 1994 ) levels may serve as a switch between apoptosis and necrosis.
Exposure of thyroid cancer cells to Zn 2+ led to a marked increase in expression of the antiapoptotic protein phosphorylated Bad, and a concurrent decrease in expression of the proapoptotic proteins Bax and Bad. This, in addition to a slight increase in Bcl-2 expression, results in an increase in the ratio of antiapoptotic proteins and proapoptotic proteins. These changes were not observed in zinc-resistant cells even after exposure to high concentrations of zinc. Furthermore, Zn 2+ increased the binding of NF-B to DNA in thyroid cancer cells. The inhibitory protein, I B, was rapidly degraded following Zn 2+ exposure, resulting in translocation of NF-B into the nucleus. Activated NF-B was mainly a heterodimer of NFKB1 (p50) and RelA (p65). Recent studies have provided convincing evidence that NF-B is involved in the inhibition of apoptosis (Beg et al. 1995 , Antwerp et al. 1996 , Beg & Baltimore 1996 , Wang et al. 1996 . These observations suggest that antiapoptotic pathways were activated in thyroid cancer cells following Zn 2+ exposure. This may be a self-defence mechanism against external apoptotic stimuli, although necrotic cell death could not be prevented. This self-defence mechanism may be one reason why thyroid cells are resistant to apoptotic stimuli (Arscott et al. 1997) .
The prognosis of anaplastic or poorly differentiated thyroid carcinomas is extremely poor because of the resistance of these cancers to chemotherapeutic agents and/or radiation. Since administration of excessive amounts of zinc compounds does not seem to result in any adverse effects (Vallee & Falchuk 1993) , the cytotoxic effect of zinc may be useful in the treatment of anaplastic and/or other thyroid cancers, especially when zinc is injected into the tumor percutaneously.
